Human Serum Albumin USP 25% Solution from Japan
A sterile solution of human serum albumin at 25% concentration, prepared from human plasma for therapeutic use in treating hypovolemia and shock. It falls under HTS 3002.90.52.50 as a blood fraction prepared for therapeutic use, derived from human blood through fractionation processes. This immunological product supports plasma volume expansion in clinical settings.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Patented pharmaceutical articles that are the product of Japan, of a European Union member country, of South Korea, of Switzerland, or of Liechtenstein as provided for in subdivisions (c) and (f) of U.S. note 40 to this subchapter
9903.05.860%Articles provided for in subdivision (b) of U.S. note 52 to this subchapter
9903.05.900%Articles of aluminum, of steel or of copper or derivative aluminum or steel articles; passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; parts of passenger vehicles (sedans, sport utility vehicles, crossover utility vehicles, minivans and cargo vans) and light trucks; medium- and heavy-duty vehicles; parts of medium- and heavy-duty vehicles; wood products; patented pharmaceutical articles; and semiconductor articles, as provided in subdivision (f) of U.S. note 52 to this subchapter
Import Tips
• Obtain FDA biologics license and ensure cold chain documentation for plasma-derived products to maintain sterility
• Provide certificates of analysis verifying viral inactivation processes to comply with blood safety regulations
• Avoid misclassification by confirming it's not unmodified blood albumin under heading 3502